Big tobacco is smart enough to realize that they can cash in on E-cigs by making and selling their own. That could be a downward spiral unless the product is as profitable as analogs. To make that happen, you have to shut down the competition. It's been rumored that BT has already started up R&D for their own product. Expect to see heavy testing of imported mixes and an eventual shutdown and ban of imported nicotine and e-liquids for whatever reason it takes to accomplish that end.
Big Pharma has a market in this because they can lobby for all e-liquid to be pharmaceutical grade nicotine, which means every bottle has to be made with nic from an approved source. BT profits and so does BP as they begin to make the nic juice from BT raw nicotine extracts. Then we join the $30 a month Nicorette purchasers at the drug store and Walmart.
Big Pharma has a market in this because they can lobby for all e-liquid to be pharmaceutical grade nicotine, which means every bottle has to be made with nic from an approved source. BT profits and so does BP as they begin to make the nic juice from BT raw nicotine extracts. Then we join the $30 a month Nicorette purchasers at the drug store and Walmart.
Last edited: